Magnitude and Factors Associated with Cytopenia Among Children on Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Science, Sidama Region, Southern Ethiopia
- PMID: 37033890
- PMCID: PMC10075263
- DOI: 10.2147/HIV.S403923
Magnitude and Factors Associated with Cytopenia Among Children on Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Science, Sidama Region, Southern Ethiopia
Abstract
Background: The most common abnormality in HIV-infected children is cytopenia, a hematological complication characterized by a decline in any of the blood cell lines. It is associated with a higher risk of morbidity and mortality. Therefore, this study aimed to assess the prevalence and associated factors of cytopenia among HIV-positive children on highly active antiretroviral therapy (HAART).
Methods: Hospital-based cross-sectional study design was conducted on HIV-positive children on HAART from July to September 2020. Socio-demographic and clinical characteristics of the study participants' data were collected using a structured questionnaire. Hematological parameters from the blood sample were analyzed using Ruby Cell-Dyne 300 hematology auto-analyzer. The data were analyzed using SPSS version 20. Logistic regression was used to assess the predictors of cytopenia among the study participants. P-values of less than 0.05 are considered statistically significant.
Results: Two hundred seventy-three HAART-experienced children were enrolled in this study, and 50.9% were females. At baseline, 40.7% of children were anemic. The overall magnitude of cytopenia among the study participants was 26.7%. The prevalence of anemia, thrombocytopenia, leucopenia and neutropenia among children was 11.4%, 4.0%, 14.3%, and 18.3%, respectively. Patients with an undetectable viral load (AOR = 0.5, CI = 0.3-0.9) are 50% less likely to report cytopenia. HAART-experienced children living in rural areas are more likely to develop cytopenia (AOR = 2.6, CI = 1.3-5.2) than those living in urban areas.
Conclusion: Hematologic abnormalities are common problems among children on highly active antiretroviral therapy. Therefore, routine investigation of hematological and immunological changes following appropriate therapeutic interventions is recommended.
Keywords: Ethiopia; HAART; HIV; children; cytopenia.
© 2023 Mohammed Nuru et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures



Similar articles
-
Anemia and Related Factors Among Highly Active Antiretroviral Therapy Experienced Children in Hawassa Comprehensive Specialized Hospital, Southern Ethiopia: Emphasis on Patient Management.Drug Healthc Patient Saf. 2020 Mar 13;12:49-56. doi: 10.2147/DHPS.S230935. eCollection 2020. Drug Healthc Patient Saf. 2020. PMID: 32214854 Free PMC article.
-
Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia.PLoS One. 2020 Sep 15;15(9):e0239215. doi: 10.1371/journal.pone.0239215. eCollection 2020. PLoS One. 2020. PMID: 32931523 Free PMC article.
-
Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study.BMC Hematol. 2014 Mar 25;14(1):8. doi: 10.1186/2052-1839-14-8. BMC Hematol. 2014. PMID: 24666771 Free PMC article.
-
Burden of anemia and its association with HAART in HIV infected children in Ethiopia: a systematic review and meta-analysis.BMC Infect Dis. 2019 Dec 4;19(1):1032. doi: 10.1186/s12879-019-4656-1. BMC Infect Dis. 2019. PMID: 31801471 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
MicroRNA target homeobox messenger RNA in HIV induced hematopoietic inhibition.Front Cell Dev Biol. 2024 Apr 24;12:1382789. doi: 10.3389/fcell.2024.1382789. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38721526 Free PMC article.
References
-
- UNAIDS. Report. Retrieved February; 2021.
-
- Anastos K, Shi Q, French AL, et al. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1–infected women receiving highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2004;35(4):383–392. doi:10.1097/00126334-200404010-00008 - DOI - PubMed
LinkOut - more resources
Full Text Sources